Results 91 to 100 of about 2,552 (169)

Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study. [PDF]

BMJ Open, 2019
Kamei T, Nakamura H, Nanki N, Minakata Y, Matsunaga K, Mori Y, for Command Study Group.   +6 more
europepmc   +1 more source

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma. [PDF]

J Clin Med Res, 2015
Alvarado-Gonzalez A, Arce I.
europepmc   +1 more source

Effect of inhaled anticholinergics on bronchial secretions: a systematic review. [PDF]

Front Physiol
Arzayus-Patiño L, Bernal-Sanchez JJ, Pérez-Hortua V, Wilches-Luna EC, Benavides-Cordoba V.   +4 more
europepmc   +1 more source

Determination of Particle Size of Active Pharmaceutical Ingredients in Dry Powder Inhaler Formulations. [PDF]

Pharmaceuticals (Basel)
Fertaki S, Orkoula M, Kontoyannis C.
europepmc   +1 more source

Efficacy of Tiotropium Bromide and Rehabilitation Treatment on Pulmonary Function of Patients With Sulfur Mustard Lung Injury. [PDF]

Iran Red Crescent Med J, 2015
Shohrati M, Jalili M, Afshar H, Najafian B, Qazvini A, Zaeri M, Amini Harandi A, Ghanei M.   +7 more
europepmc   +1 more source

Comprehensive management of a chronic patient in community pharmacy: impact of Comprehensive Medication Management on health outcomes and quality of life. [PDF]

Farm Comunitarios
Pérez Rodríguez RO, González Valdivieso M, Blázquez Ferrer MA.   +2 more
europepmc   +1 more source

Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate [PDF]

Allergy Asthma Clin Immunol, 2014
Hanna M, Mack D.
europepmc   +1 more source

Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Rebordosa C, Aguado J, Bartsch J, Saigi-Morgui N, Carsin AE, Garcia-Esteban R, Ignatova E, Freedman D, Perez-Gutthann S, Rivero-Ferrer E.   +9 more
europepmc   +1 more source

Real world pharmacovigilance study of FDA adverse event reporting system events for Spiriva Respimat. [PDF]

Front Med (Lausanne)
Chen K, Zhao S, Deng W, Ma Q, Xiao H.
europepmc   +1 more source

Economic evaluation of generic inhalational bronchodilators from the Jan-Aushadi scheme versus branded alternatives. [PDF]

Cost Eff Resour Alloc
James J, Vinod NP, Manohar MM, Kumaran B R.   +3 more
europepmc   +1 more source